Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05255679
Other study ID # Pro00100619
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 21, 2021
Est. completion date October 31, 2023

Study information

Verified date February 2024
Source University of Alberta
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Spinal cord injury (SCI) is a devastating condition that often leads to paralysis and multiple health problems such as muscle wasting, bone loss and spasticity. Despite the paralysis, functional electrical stimulation (FES) on the skin surface muscles may produce muscle contractions. People who have had an SCI for a long time (chronic SCI) already use FES cycling to exercise, and it is known that it can reverse muscle atrophy and has a wide range of health benefits. Furthermore, animal research suggests that starting exercise training early after new SCI may promote spinal cord recovery. However, not much is known about early FES cycling in humans. Therefore, the investigators propose to study if early FES cycling could prevent muscle wasting, pain or spasticity, and help with spinal cord recovery. The study will recruit 36 participants with a new, acute SCI, between 14 and 21 days after their injury into 3 groups. An Early-FES group starts FES cycling early after injury (between 14 and 21 days after injury), and for a duration of 6 months. A Delayed-FES group starts FES cycling 3 months after enrolling in the study, and for a duration of 3 months. A Control group does not perform FES cycling. This pilot study will allow us to study if early FES cycling, in addition to normal care, has greater benefits on the preservation and recovery of the leg muscles and spinal cord function than delayed FES cycling or standard care only. The results of this pilot study may lead to the development of a larger study with early FES cycling after new SCI.


Description:

Spinal cord injury (SCI) usually results in weakness or paralysis in the legs and/or arms, depending on the level and severity of the damage to the spinal cord. In addition, people with SCI often develop several complications in the long term, such as muscle wasting (atrophy), loss of bone strength, pain, and spasticity. Despite the weakness or paralysis, the muscles in a person with SCI can be activated using electrical stimulation applied on the skin surface of the muscles. This technique is called functional electrical stimulation (FES) and can be used in combination with a bike to perform a cycling movement (FES cycling). People who have had an SCI for a long time (chronic SCI) already use FES cycling to exercise, and it is known that it can reverse muscle atrophy and has a wide range of health benefits. Furthermore, animal research suggests that starting exercise training early after new SCI may promote spinal cord recovery. However, not much is known about early FES cycling in humans, for example, if it could prevent muscle atrophy, pain or spasticity, and help with recovery of the spinal cord. Therefore, the investigators propose to study if early FES cycling may prevent these complications and help with spinal cord recovery. The study will recruit 36 participants with a new SCI, in 3 groups. The Early-FES group starts FES cycling early after injury (between 14 and 21 days after injury), and for a duration of 6 months. A Delayed-FES group starts FES cycling 3 months after enrolling in the study, and for a duration of 3 months. A Control group does not perform FES cycling. People with an acute, complete or incomplete SCI that resulted in paralysis from the waist down (paraplegia) or neck down (quadriplegia) will be considered. The Early and Delayed FES group will be recruited from the University of Alberta Hospital (UAH) where the FES bikes are available. Participants will be assigned by chance into Early and Delayed FES group. The control group will be mainly recruited from the Royal Alexandra Hospital, where the FES bikes are currently not available. The FES groups will perform FES cycling sessions 3 times per week (up to 1 hour per session) and receive standard care (typically including physical and occupational therapy). The Control group will only receive standard care. The FES cycling will be performed while the participants are lying in bed using a bed bike, or while sitting in a wheel chair using chair-based bike. Both systems use pedals that are strapped to the feet and an electrical stimulator to activate several muscles of both legs using electrodes attached to the skin. The following will be measured: 1) the size of the leg muscles and amount of fat in the legs using a CT scanner. 2) strength of the muscles using manual tests and by the electrical signals in the muscle. 3) spasticity by measuring electrical responses in the muscle when stimulated, as well as with clinical scales. 4) strength of the electrical connections between brain and spinal cord. 5) clinical measures such as the spinal injury classification, pain and reflexes. 6) response of participants to the FES cycling program. 7) cost and health care resources for the administration of early and delayed FES cycling. All 3 groups will undergo the same assessments. This pilot study will allow the investigators to study if early FES cycling, in addition to standard care, has greater benefits on the preservation and recovery of the leg muscles and spinal cord function than standard care only. The results of this pilot study may lead to the development of a multi-center clinical trial with early FES cycling after new SCI, which may have important and innovative implications in the future rehabilitation practice, improving the health, function and quality of life of persons with SCI.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date October 31, 2023
Est. primary completion date August 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Traumatic or non-traumatic SCI - Acute onset of SCI - Able to start FES cycling 14-21 days post injury - Injury level C1 - L5 - AIS A, B, C, D (ASIA Impairment Scale) - Medically stable Absolute Contraindications and Exclusion Criteria 1. AIS D, able to walk without assistive device 2. Unstable spine fractures 3. Unstable fractures/dislocations in lower extremities or pelvis 4. Pregnancy 5. Unable to give consent to participate in the study 6. Contraindications for TMS (Transcranial Magnetic Stimulation). Relative Contraindications and Exclusion Criteria (Exclusion or Caution) 1. Lower motor neuron injury with insufficient muscle contraction with FES 2. Peripheral nerve or root injury resulting in denervated lower limb muscles 3. History of severe hip or knee instability or dislocation/subluxation 4. Osteoporosis in lower extremities that could result in fracture from cycling 5. Osteoarthritis in lower extremities 6. Limited range of motion in hip and knee preventing cycling 7. History of epilepsy not effectively managed by medication 8. History of heart problems (coronary artery disease / myocardial infarction / congestive heart failure) 9. Implanted cardiac demand pacemaker 10. Implanted stimulators: diaphragmatic, epidural, vagus nerve, phrenic 11. Malignant tumor in stimulated areas 12. Thrombophlebitis or thrombosis in stimulated area 13. Skin lesions or open wounds at any potential electrode site 14. Pressure ulcers that could deteriorate from cycling 15. Spasticity 16. Autonomic dysreflexia 17. Active heterotopic ossification in lower extremities 18. Extreme edema or adipose tissue in legs 19. Any other contraindications to participate in an active exercise program

Study Design


Intervention

Device:
Early FES
FES cycling starting 14-21 days post SCI for 6 months, 3 sessions/week, with gradually increasing duration (15-60 minutes), cadence (20-45 RPM) and resistance; surface stimulation of 3-5 muscle groups per leg; with RT300 Supine or SLSA FES cycle (Restorative Therapies, Inc, Baltimore, MD)
Delayed FES
FES cycling starting 3 months (+ 14-21 days) post SCI, for 3 months, 3 sessions/week, with gradually increasing duration (15-60 minutes), cadence (20-45 RPM) and resistance; surface stimulation of 3-5 muscle groups per leg; with RT300 Supine or SLSA FES cycle (Restorative Therapies, Inc, Baltimore, MD)

Locations

Country Name City State
Canada University of Alberta Edmonton Alberta

Sponsors (3)

Lead Sponsor Collaborator
University of Alberta Glenrose Foundation, Royal Alexandra Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle cross-sectional area thigh and calf: Change from 0 to 3 months Muscle cross sectional area measured from multiple transverse CT scan slices across thigh and calf 3 months
Primary Muscle cross-sectional area thigh and calf: Change from 3 months to 6 months Muscle cross sectional area measured from multiple transverse CT scan slices across thigh and calf 3 months
Primary Spasticity legs: Change from 0 to 3 months Size of the cutaneomuscular reflex (CMR) produced by electrical stimulation of the medial arch of the foot and measured in the electromyogram (EMG) from several muscles in the leg (tibialis anterior, soleus, quadriceps and hamstrings). 3 months
Primary Spasticity legs: Change from 3 months to 6 months Size of the cutaneomuscular reflex (CMR) produced by electrical stimulation of the medial arch of the foot and measured in the electromyogram (EMG) from several muscles in the leg (tibialis anterior, soleus, quadriceps and hamstrings). 3 months
Primary Corticospinal excitability: Change from 0 to 3 months Size of the motor evoke potentials (MEP) produced by transcranial magnetic stimulation of the motor cortex, and measured in the EMG of several leg muscles (tibialis anterior, soleus, quadriceps and hamstrings). 3 months
Primary Corticospinal excitability: Change from 3 months to 6 months Size of the motor evoke potentials (MEP) produced by transcranial magnetic stimulation of the motor cortex, and measured in the EMG of several leg muscles (tibialis anterior, soleus, quadriceps and hamstrings). 3 months
Primary Spinal cord excitability: Change from 0 to 3 months Hmax/Mmax ratio, based on H-reflex and M-wave measurements in soleus EMG during tibial nerve stimulation, will be quantified as a measure of general spinal cord excitability (sensory transmission and motoneuron excitability) 3 months
Primary Spinal cord excitability: Change from 3 months to 6 months Hmax/Mmax ratio, based on H-reflex and M-wave measurements in soleus EMG during tibial nerve stimulation, will be quantified as a measure of general spinal cord excitability (sensory transmission and motoneuron excitability) 3 months
Primary Muscle strength: Change from 0 to 3 months Size of the EMG measured during maximum voluntary contraction in tibialis anterior, soleus, quadriceps and hamstrings. 3 months
Primary Muscle strength: Change from 3 months to 6 months Size of the EMG measured during maximum voluntary contraction in tibialis anterior, soleus, quadriceps and hamstrings. 3 months
Secondary SCI Classification at Baseline Spinal cord injury classification based on the American Spinal Injury Association (ASIA) Injury Scale (AIS), according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range AIS A, B, C, D (most-least severe injury) Baseline
Secondary SCI Classification at 3 months Spinal cord injury classification based on the American Spinal Injury Association (ASIA) Injury Scale (AIS), according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range AIS A, B, C, D (most-least severe injury) 3 months
Secondary SCI Classification at 6 months Spinal cord injury classification based on the American Spinal Injury Association (ASIA) Injury Scale (AIS), according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range AIS A, B, C, D (most-least severe injury) 6 months
Secondary Motor scores: Change from 0 to 3 months Sum of motor scores based on manual muscle strength testing of 5 key upper limb and 5 key lower limb muscle groups bilaterally according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range worst-best score 0-100. 3 months
Secondary Motor scores: Change from 3 months to 6 months Sum of motor scores based on manual muscle strength testing of 5 key upper limb and 5 key lower limb muscle groups bilaterally according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range worst-best score 0-100. 3 months
Secondary Sensory scores: Change from 0 to 3 months Sum of sensory scores in response to light touch and pinprick at 28 key sensory points on each side of the whole body, according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range worst-best score 0-224. 3 months
Secondary Sensory scores: Change from 3 months to 6 months Sum of sensory scores in response to light touch and pinprick at 28 key sensory points on each side of the whole body, according to the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Range worst-best score 0-224. 3 months
Secondary Pain intensity: Change from 0 to 3 months Pain intensity assessment using the International Spinal Cord Injury Pain Basic Data Set v2. The tool scores intensity using an 11-point numeric scale (Range best-worst score 0-10). In addition the tool describes pain over the previous 7 days, impact of pain, type of pain (nociceptive vs. neuropathic), intensity and duration of pain, and treatment for pain. 3 months
Secondary Pain intensity: Change from 3 months to 6 months Pain intensity assessment using the International Spinal Cord Injury Pain Basic Data Set v2. The tool scores intensity using an 11-point numeric scale (Range best-worst score 0-10). In addition the tool describes pain over the previous 7 days, impact of pain, type of pain (nociceptive vs. neuropathic), intensity and duration of pain, and treatment for pain. 3 months
Secondary Leg cross-sectional area thigh and calf: Change from 0 to 3 months Leg cross-sectional area calculated based on circumferences of thigh and calf measured with tape measure, and corrected for skinfold thickness (measure of subcutaneous fat) measured with skinfold caliper at same locations. 3 months
Secondary Leg cross-sectional area thigh and calf: Change from 3 months to 6 months Leg cross-sectional area calculated based on circumferences of thigh and calf measured with tape measure, and corrected for skinfold thickness (measure of subcutaneous fat) measured with skinfold caliper at same locations. 3 months
Secondary Walking Speed: Change from 0 to 3 months Depending in the participant's capabilities, walking speed will be assessed with the 10-meter walking test (measuring time taken to walk 10 meters), and/or the 6-minute walking test (measuring distance walked in 6 minutes) 3 months
Secondary Walking Speed: Change from 3 months to 6 months Depending in the participant's capabilities, walking speed will be assessed with the 10-meter walking test (measuring time taken to walk 10 meters), and/or the 6-minute walking test (measuring distance walked in 6 minutes) 3 months
Secondary Walking Capability: Change from 0 to 3 months Scored using the Walking Index for Spinal Cord Injury (WISCI II), giving a ranking from most severe impairment (0) to least severe impairment (20) based on the use of devices, braces and physical assistance of one or more persons. 3 months
Secondary Walking Capability: Change from 3 months to 6 months Scored using the Walking Index for Spinal Cord Injury (WISCI II), giving a ranking from most severe impairment (0) to least severe impairment (20) based on the use of devices, braces and physical assistance of one or more persons. 3 months
Secondary Spasticity self-report: Change from 0 to 3 months Frequency and severity of the spasticity, its interference with function, and association with pain, scored using 11-point numeric scales. Range 0-10, with best (0) to worst (10). 3 months
Secondary Spasticity self-report: Change from 3 months to 6 months Frequency and severity of the spasticity, its interference with function, and association with pain, scored using 11-point numeric scales. Range 0-10, with best (0) to worst score (10). 3 months
Secondary Depression at 3 months Total score derived from the Patient Health Questionnaire (PHQ-9 ) which includes 9 questions related to signs of depression. Range best-worst score 0-27. 3 months
Secondary Depression at 6 months Total score derived from the Patient Health Questionnaire (PHQ-9 ) which includes 9 questions related to signs of depression. Range best-worst score 0-27. 6 months
Secondary Psychosocial status of participants as assessed by AQol-8D at 3 months Total score derived from the Assessment of Quality of Life (AQol-8D), measuring 8 dimensions of quality of life. Range worst-best score 35-176.
Score derived from EQ-5D-5L Quality of Life Tool (EuroQol Research Foundation), measuring 5 dimensions. Range best-worst score 5-25.
3 months
Secondary Psychosocial status of participants as assessed by AQol-8D at 6 months Total score derived from the Assessment of Quality of Life (AQol-8D), measuring 8 dimensions of quality of life. Range worst-best score 35-176.
Score derived from EQ-5D-5L Quality of Life Tool (EuroQol Research Foundation), measuring 5 dimensions. Range best-worst score 5-25.
6 months
Secondary Program Cost Cost and health care resources for the administration of early and delayed FES 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04811235 - Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial N/A
Completed NCT00406016 - Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI Phase 1
Recruiting NCT05305118 - TSCS for Acute SCI N/A
Recruiting NCT05244408 - "SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
Recruiting NCT05731986 - Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI) N/A
Recruiting NCT06452264 - Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study N/A
Recruiting NCT05426681 - Spinal Cord Injury Neuroprotection With Glyburide Phase 1
Recruiting NCT04056988 - tSCI Contrast Enhanced Ultrasound Study Phase 4
Recruiting NCT05745298 - The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury N/A
Terminated NCT01750684 - AC105 in Patients With Acute Traumatic Spinal Cord Injury Phase 2
Recruiting NCT04475224 - Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury Phase 3
Enrolling by invitation NCT06030531 - Spasticity and Functional Recovery After SCI
Active, not recruiting NCT03935724 - Stem Cells in Spinal Cord Injury Phase 2/Phase 3
Recruiting NCT04054414 - PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury Phase 2
Recruiting NCT06000592 - Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI N/A
Completed NCT02325414 - Prevention of Bone Loss After Acute SCI by Zoledronic Acid Phase 2
Recruiting NCT02034669 - Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment Phase 1/Phase 2
Terminated NCT02232165 - Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury N/A
Completed NCT02260713 - Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study. Phase 1/Phase 2
Terminated NCT02524379 - Spinal Cord Injury Neuroprotection With Glyburide Phase 1/Phase 2